Total
0
Shares
dorsaVi (ASX:DVL) -
CEO, Andrew Ronchi Source: North Road Physiotherapy
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • dorsaVi (DVL) extends its master services agreement (MSA) with medical technology and services provider Medtronic by six months
  • The parties signed an initial 12-month agreement in March
  • The extension will allow for further optimisation of DVL’s medical-grade sensor technology by building on insights gathered so far
  • While the original MSA was valued at around US$330,000 (A$446,500), the six-month addition tacks on roughly US$171,000 (A$231,000)
  • dorsaVi shares have closed flat at 2.6 cents on August 5

dorsaVi (DVL) has extended its agreement with medical technology and services provider Medtronic for a further six months.

DVL develops innovative motion analysis devices for use in clinical applications, elite sports, and occupational health and safety.

The parties solidified their commercial relationship through an initial master services agreement (MSA) signed back in March, following an evaluation deal made in December last year.

The companies agreed to analyse data on patients wearing dorsaVi medical-grade sensors over an initial 12-month period.

To this end, the six-month extension is said to be worth roughly US$171,000 (A$231,000) on top of the MSA’s original value in the realm of US$330,000 (A$446,500).

Accordingly, DVL said the longer deal aimed to further optimise its technology by building on the insights gathered from the MSA so far.

dorsaVi CEO Andrew Ronchi said the extension of the agreement was a testament to the hard work of his team and was a strong validation of DVL’s world-leading technology.

“This agreement further highlights the different potential uses of our technology, exploring new applications and potential partnerships to deliver shareholder value,” Dr Ronchi said.

DVL’s partner Medtronic is headquartered in Dublin and has operations in 150 countries worldwide. The company is focussed on alleviating pain, restoring health and extending life for millions of people around the world.

dorsaVi shares closed flat at 2.6 cents on August 5.

DVL by the numbers
More From The Market Herald
PlaySide Studios (ASX:PLY) - CEO, Gerry Sakkas

" PlaySide Studios (ASX:PLY) signs contract with Shiba Inu Games

Playside Studios (PLY) has signed a material work-for-hire contract with Shiba Inu Games, a derivative entity formed from the globally-recognised cryptocurrency, Shiba Inu.

" RocketBoots (ASX:ROC) lists on ASX after $4.25m IPO

Software company RocketBoots (ROC) has debuted on the ASX today after raising $4.25 million through an initial public offer (IPO).
Traffic Technologies (ASX:TTI) - Non Executive Chairman, Mark Hardgrave

" Traffic Technologies (ASX:TTI) raises $3.4m from rights issue

Traffic Technologies (TTI) has raised $3.4 million to repay existing debt and bolster its working capital balance.

" IODM (ASX:IOD) secures new revenue opportunity from WUBS partnership

Software solution company, IODM (IOD) has received a new revenue opportunity from its existing partnership with Western Union Business Solutions (WUBS).